
Opinion|Videos|September 13, 2024
Biosimilar Copay Programs
Author(s)Sophia Humphreys, PharmD, MHA
Dr Humphreys discusses biosimilar copay programs.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- How do copay programs impact the adoption of biosimilars for patients, and what role can the pharmacy staff play in educating patients about these programs?
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Updated Hypertension Guidelines Are Here
2
Carefully Consider Ethical Implications of Artificial Intelligence Use in Pharmacy
3
Gluteus Maximus Muscle Shape Changes Tied to Aging, Frailty, and Type 2 Diabetes
4
FDA Approves Reformulated Ranitidine After 5-Year Absence
5














































































































































































































